Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Online Access: | https://doi.org/10.1007/s00262-024-03874-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571664515203072 |
|---|---|
| author | Airi Fujimoto Yoshimichi Koutake Daisuke Hisamatsu Noriko Ookubo Yurika Yabuuchi Go Kamimura Tatsuo Kai Aki Kozono Takahiro Ootsu Hiroto Suzuki Keisuke Matsuo Kimiko Kuwahara Yoshita Oiwane Yuko Nagata Kenya Tanimoto Eri Sato Mei Suenaga Tomohiro Uehara Akira Ikari Satoshi Endo Yoichi Hiraki Yosei Kawamata |
| author_facet | Airi Fujimoto Yoshimichi Koutake Daisuke Hisamatsu Noriko Ookubo Yurika Yabuuchi Go Kamimura Tatsuo Kai Aki Kozono Takahiro Ootsu Hiroto Suzuki Keisuke Matsuo Kimiko Kuwahara Yoshita Oiwane Yuko Nagata Kenya Tanimoto Eri Sato Mei Suenaga Tomohiro Uehara Akira Ikari Satoshi Endo Yoichi Hiraki Yosei Kawamata |
| author_sort | Airi Fujimoto |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7d55d53fd699440ca3c9fc982a7c1966 |
| institution | Kabale University |
| issn | 1432-0851 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Springer |
| record_format | Article |
| series | Cancer Immunology, Immunotherapy |
| spelling | doaj-art-7d55d53fd699440ca3c9fc982a7c19662025-02-02T12:26:38ZengSpringerCancer Immunology, Immunotherapy1432-08512024-12-017411210.1007/s00262-024-03874-4Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto0Yoshimichi Koutake1Daisuke Hisamatsu2Noriko Ookubo3Yurika Yabuuchi4Go Kamimura5Tatsuo Kai6Aki Kozono7Takahiro Ootsu8Hiroto Suzuki9Keisuke Matsuo10Kimiko Kuwahara11Yoshita Oiwane12Yuko Nagata13Kenya Tanimoto14Eri Sato15Mei Suenaga16Tomohiro Uehara17Akira Ikari18Satoshi Endo19Yoichi Hiraki20Yosei Kawamata21Department of Pharmacy, National Hospital Organization Beppu Medical CenterDepartment of Pharmacy, Clinical Research Institute, National Hospital Organization Kyushu Medical CenterDepartment of Pharmacy, National Hospital Organization Kyushu Cancer CenterDepartment of Pharmacy, National Hospital Organization Miyakonojo Medical CenterDepartment of Pharmacy, National Hospital Organization Fukuokahigashi Medical CenterDepartment of Pharmacy, National Hospital Organization Minamikyusyu HospitalDepartment of Pharmacy, National Hospital Organization Miyazaki Higashi HospitalDepartment of Pharmacy, National Hospital Organization Kumamoto Saishun Medical CenterDepartment of Pharmacy, National Hospital Organization Nagasaki Medical CenterDepartment of Pharmacy, National Hospital Organization Okinawa National HospitalDepartment of Pharmacy, National Hospital Organization Beppu Medical CenterDepartment of Pharmacy, National Hospital Organization Ureshino Medical CenterDepartment of Pharmacy, National Hospital Organization Omuta National HospitalDepartment of Pharmacy, National Hospital Organization Fukuoka National HospitalDepartment of Pharmacy, National Hospital Organization Kagoshima Medical CenterDepartment of Pharmacy, National Hospital Organization Miyakonojo Medical CenterDepartment of Pharmacy, National Hospital Organization Kumamoto Saishun Medical CenterDepartment of Pharmacy, National Hospital Organization Okinawa National HospitalLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical UniversityLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical UniversityDepartment of Pharmacy, National Hospital Organization Beppu Medical CenterDepartment of Pharmacy, Clinical Research Institute, National Hospital Organization Kyushu Medical Centerhttps://doi.org/10.1007/s00262-024-03874-4 |
| spellingShingle | Airi Fujimoto Yoshimichi Koutake Daisuke Hisamatsu Noriko Ookubo Yurika Yabuuchi Go Kamimura Tatsuo Kai Aki Kozono Takahiro Ootsu Hiroto Suzuki Keisuke Matsuo Kimiko Kuwahara Yoshita Oiwane Yuko Nagata Kenya Tanimoto Eri Sato Mei Suenaga Tomohiro Uehara Akira Ikari Satoshi Endo Yoichi Hiraki Yosei Kawamata Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study Cancer Immunology, Immunotherapy |
| title | Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study |
| title_full | Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study |
| title_fullStr | Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study |
| title_full_unstemmed | Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study |
| title_short | Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study |
| title_sort | correction risk factors indicating immune related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non small cell lung cancer a multicenter retrospective study |
| url | https://doi.org/10.1007/s00262-024-03874-4 |
| work_keys_str_mv | AT airifujimoto correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yoshimichikoutake correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT daisukehisamatsu correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT norikoookubo correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yurikayabuuchi correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT gokamimura correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT tatsuokai correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT akikozono correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT takahiroootsu correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT hirotosuzuki correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT keisukematsuo correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT kimikokuwahara correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yoshitaoiwane correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yukonagata correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT kenyatanimoto correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT erisato correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT meisuenaga correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT tomohirouehara correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT akiraikari correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT satoshiendo correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yoichihiraki correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy AT yoseikawamata correctionriskfactorsindicatingimmunerelatedadverseeventswithcombinationchemotherapywithimmunecheckpointinhibitorsandplatinumagentsinpatientswithnonsmallcelllungcanceramulticenterretrospectivestudy |